Successful treatment of alopecia universalis with alefacept: a case report and review of the literature

Cutis. 2008 May;81(5):431-4.

Abstract

Alopecia universalis often responds poorly to standard therapies. We report how a novel treatment option, alefacept, was successfully used in the management of a 21-year-old woman with alopecia universalis. The patient responded with complete regrowth of scalp and body hair after a single 12-week treatment course of alefacept. In addition, a review of the literature was performed pertaining to the use of biologic agents in the treatment of alopecia areata/universalis to determine which agents have a potential role in the treatment of this often refractory disease.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adalimumab
  • Adult
  • Alefacept
  • Alopecia / chemically induced
  • Alopecia / drug therapy*
  • Alopecia / immunology
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects
  • Immunoglobulin G / therapeutic use
  • Immunologic Factors / adverse effects
  • Immunologic Factors / therapeutic use*
  • Infliximab
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Recombinant Fusion Proteins / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Immunologic Factors
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Infliximab
  • Alefacept
  • Adalimumab
  • Etanercept
  • efalizumab